Conversations Contributors - Steven Grossman

From 1989 to 2000, Mr. Grossman was senior managing director and director of health policy in Hill and Knowlton’s Washington office. He developed and implemented public affairs, communications and crisis management programs for health care, pharmaceutical and food clients. He also counseled clients on policy, strategy, corporate communications, regulation, and legislation.

Conversations Contributors - Rebecca D. Kush, Ph.D.

Rebecca Daniels Kush, Ph.D. is Founder, President and CEO of the Clinical Data Interchange Standards Consortium (CDISC), a non-profit standards developing organization (SDO) with a focus on global clinical research standards and a vision of “Informing patient care and safety through higher quality medical research”.

Conversations Contributors - Richard Pops

Richard Pops serves as Chairman and Chief Executive Officer of Alkermes. He joined Alkermes as CEO in 1991. Under his leadership, Alkermes has grown from a privately held company with 25 employees to an international, publicly traded biopharmaceutical company with more than 1,200 employees and a portfolio of more than 20 commercial products. Mr.

Conversations Contributors - Andrew Emmett

One Year Anniversary of PDUFA V

09.30.13 | By

In 1992, under the Prescription Drug User Fee Act (PDUFA), the U.S. Food and Drug Administration (FDA) began collecting fees from biopharmaceutical companies to provide much needed resources to keep new medicines moving through the approval process and into the hands of patients. 

Conversations on Medicare Part D

09.30.13 | By

In 2003, through the Medicare Modernization Act, Congress established the Medicare prescription drug benefit - better known as Part D. Ten years later, at a cost significantly below initial estimates, the program is successfully providing affordable access to prescription drugs for more than 30 million seniors and people with disabilities.

PhRMA Conversations - Medicare Part D and its Promise

09.25.13 | By

In 2003, the Medicare Prescription Drug, Improvement, and Modernization Act was passed by Congress and signed into law by President George W. Bush. This landmark legislation created the Medicare prescription drug benefit (Part D) – a federal program that provides affordable drug coverage to millions of seniors and people with disabilities.

Conversations Contributors - Bobbie Ann Brinegar

Bobbie Ann Brinegar is a thought leader and experienced nonprofit executive who has led successful initiatives to maintain the integrity of voting systems used in American elections and secure programs that will preserve social security income and provide affordable and accessible health care for women.

Conversations Contributors - Tommy Thompson

Conversations

As we come upon the 10th anniversary of the Medicare Part D program, is it still living up to its promise? What can be done to improve it?

Contributors Respond

Pages

Subscribe to RSS - conversations